Vanguard Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $73.1M | Sell |
|
|||||
|
2025
Q2 | $66.7M | Buy |
|
|||||
|
2025
Q1 | $83M | Sell |
|
|||||
|
2024
Q4 | $96.4M | Sell |
|
|||||
|
2024
Q3 | $98.4M | Buy |
|
|||||
|
2024
Q2 | $114M | Buy |
|
|||||
|
2024
Q1 | $125M | Buy |
|
|||||
|
2023
Q4 | $124M | Buy |
|
|||||
|
2023
Q3 | $105M | Buy |
|
|||||
|
2023
Q2 | $251M | Sell |
|
|||||
|
2023
Q1 | $239M | Buy |
|
|||||
|
2022
Q4 | $255M | Buy |
|
|||||
|
2022
Q3 | $191M | Buy |
|
|||||
|
2022
Q2 | $209M | Buy |
|
|||||
|
2022
Q1 | $200M | Buy |
|
|||||
|
2021
Q4 | $307M | Buy |
|
|||||
|
2021
Q3 | $314M | Buy |
|
|||||
|
2021
Q2 | $296M | Buy |
|
|||||
|
2021
Q1 | $304M | Buy |
|
|||||
|
2020
Q4 | $157M | Buy |
|
|||||
|
2020
Q3 | $190M | Buy |
|
|||||
|
2020
Q2 | $14.7M | Buy |
|
|||||
|
2020
Q1 | $6.08M | Buy |
|
|||||
|
2019
Q4 | $2.14M | Buy |
|